Next-Generation Sequencing (NGS) Market


Posted August 18, 2022 by Drachana

The market is expected to witness a CAGR of ~20.5% from 2021 to 2031.

 
Rising prevalence of chronic diseases globally, the launch of technologically advanced systems, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, and application of NGS in precision medicine & molecular diagnostics are some of the pivotal factors propelling the growth of next-generation sequencing (NGS) market. However, ethical concerns associated with NGS technology are likely to restrain the market growth to a certain extent.

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) to Illumina, Inc. for the first COVID-19 diagnostic test utilizing next-generation sequence technology. The FDA authorized the Illumina COVID Seq Test for the qualitative detection of SARS-CoV-2 RNA from respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. Improving reimbursement scenarios for NGS technology in various countries is likely to lead to higher adoption of NGS technology and thereby is expected to boost the growth of the market.
To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/next-generation-sequencing-(ngs)-market/7680
The report includes an in-depth study of the global market Next-Generation Sequencing (NGS), where segments and sub-segments are analysed in quite a detail. This research will help players focus on high-growth segments and modify their business strategies if needed. The Diabetes Care Devices global market is segmented based on Products, Technology, and End Users. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our researchers and analysts use reliable primary and secondary sources for research and data.
Key players:
Illumina, Inc., Thermo Fisher Scientific, PerkinElmer Inc., QIAGEN, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Takara Bio Inc., GENEWIZ, BGI, Macrogen Oceania, among others.
Segmentation By Technology:
• Sequencing by Synthesis
• Ion Semiconductor Sequencing
• Single-molecule Real-time Sequencing
By Application
• Diagnostics and Drug Discovery
• Development
Regional Analysis-
• The Asia-Pacific market is anticipated to grow at a higher CAGR during the forecast period.
• Major factors contributing to the growth of Next-Generation Sequencing (NGS) market in this region include the rising incidence of chronic infectious diseases, rising awareness regarding growing applications of Next-Generation Sequencing (NGS), and increasing research activities in the field of Next-Generation Sequencing (NGS).
• The emergence of local players and new product launches has also played a critical role in boosting the Next-Generation Sequencing (NGS) market in this region.
Browse the full report now: https://growthplusreports.com/report/next-generation-sequencing-(ngs)-market/7680
Key Questions Answered in the Report Include:
(1) This report gives all the information about the industry analysis, revenue, and overview, of this market.
(2) What will be the rate of increase in market size and growth rate by the end of the forecast period?
(3) What are the major global Next-Generation Sequencing (NGS) Market trends influencing the development of the market?
(4) What are the vital results of SWOT analysis of the major players operating in the Next-Generation Sequencing (NGS) Market?
(5) What are the potential growth opportunities and threats faced by Major competitors in the market?
About Us:
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By growthplusreports
Country India
Categories Biotech , Health , Lifestyle
Tags market , marketsize , ngs
Last Updated August 18, 2022